Literature DB >> 22589299

Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica.

Andrea Rossi, Julien Ratelade, Marios C Papadopoulos, Jeffrey L Bennett, A S Verkman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22589299      PMCID： PMC3386066          DOI： 10.1073/pnas.1203463109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica.

Authors:  Julien Ratelade; Jeffrey L Bennett; A S Verkman
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

2.  Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays.

Authors:  Puay-Wah Phuan; Julien Ratelade; Andrea Rossi; Lukmanee Tradtrantip; A S Verkman
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

3.  Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes.

Authors:  Shannon R Hinson; Michael F Romero; Bogdan F Gh Popescu; Claudia F Lucchinetti; James P Fryer; Hartwig Wolburg; Petra Fallier-Becker; Susan Noell; Vanda A Lennon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-29       Impact factor: 11.205

4.  Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.

Authors:  Grazia Paola Nicchia; Mauro Mastrototaro; Andrea Rossi; Francesco Pisani; Carla Tortorella; Maddalena Ruggieri; Anna Lia; Maria Trojano; Antonio Frigeri; Maria Svelto
Journal:  Glia       Date:  2009-10       Impact factor: 7.452

5.  Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.

Authors:  Shannon R Hinson; Shanu F Roemer; Claudia F Lucchinetti; James P Fryer; Thomas J Kryzer; Jayne L Chamberlain; Charles L Howe; Sean J Pittock; Vanda A Lennon
Journal:  J Exp Med       Date:  2008-10-06       Impact factor: 14.307
  5 in total
  12 in total

Review 1.  Aquaporin 4 and neuromyelitis optica.

Authors:  Marios C Papadopoulos; A S Verkman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

2.  Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes.

Authors:  Andrea Rossi; Tobias J Moritz; Julien Ratelade; A S Verkman
Journal:  J Cell Sci       Date:  2012-06-20       Impact factor: 5.285

Review 3.  Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies.

Authors:  Julien Ratelade; A S Verkman
Journal:  Int J Biochem Cell Biol       Date:  2012-06-17       Impact factor: 5.085

Review 4.  Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy.

Authors:  Jeffrey L Bennett; Gregory P Owens
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

5.  Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders.

Authors:  Valentina Damato; Jakob Theorell; Adam Al-Diwani; Anne-Kathrin Kienzler; Mateusz Makuch; Bo Sun; Adam Handel; Deniz Akdeniz; Antonio Berretta; Sudarshini Ramanathan; Andrew Fower; Daniel Whittam; Emily Gibbons; Nicholas McGlashan; Edward Green; Saif Huda; Mark Woodhall; Jacqueline Palace; Fintan Sheerin; Patrick Waters; Maria I Leite; Anu Jacob; Sarosh R Irani
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-06       Impact factor: 12.779

6.  Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.

Authors:  Andrea Rossi; Julien Ratelade; Marios C Papadopoulos; Jeffrey L Bennett; A S Verkman
Journal:  Glia       Date:  2012-09-14       Impact factor: 7.452

Review 7.  The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.

Authors:  Claudia F Lucchinetti; Yong Guo; Bogdan F Gh Popescu; Kazuo Fujihara; Yasuto Itoyama; Tatsuro Misu
Journal:  Brain Pathol       Date:  2014-01       Impact factor: 6.508

Review 8.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

Review 9.  Molecular pathogenesis of neuromyelitis optica.

Authors:  Wajih Bukhari; Michael H Barnett; Kerri Prain; Simon A Broadley
Journal:  Int J Mol Sci       Date:  2012-10-11       Impact factor: 5.923

10.  Supramolecular aggregation of aquaporin-4 is different in muscle and brain: correlation with tissue susceptibility in neuromyelitis optica.

Authors:  Stefania Rosito; Grazia Paola Nicchia; Claudia Palazzo; Anna Lia; Cinzia Buccoliero; Francesco Pisani; Maria Svelto; Maria Trojano; Antonio Frigeri
Journal:  J Cell Mol Med       Date:  2017-10-20       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.